Frontiers in Medicine (Jan 2023)

Standardized classification schemes in reporting oncologic PET/CT

  • Vanessa Murad,
  • Vanessa Murad,
  • Roshini Kulanthaivelu,
  • Roshini Kulanthaivelu,
  • Claudia Ortega,
  • Claudia Ortega,
  • Patrick Veit-Haibach,
  • Patrick Veit-Haibach,
  • Ur Metser,
  • Ur Metser

DOI
https://doi.org/10.3389/fmed.2022.1051309
Journal volume & issue
Vol. 9

Abstract

Read online

The imaging report is essential for the communication between physicians in patient care. The information it contains must be clear, concise with evidence-based conclusions and sufficient to support clinical decision-making. In recent years, several classification schemes and/or reporting guidelines for PET have been introduced. In this manuscript, we will review the classifications most frequently used in oncology for interpreting and reporting 18F-FDG PET imaging in lymphoma, multiple myeloma, melanoma and head and neck cancers, PSMA-ligand PET imaging for prostate cancer, and 68Ga-DOTA-peptide PET in neuroendocrine tumors (NET).

Keywords